Skeletal muscle atrophy is induced by Fbxw7β via atrogene upregulation

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Muscle atrophy, a decrease in skeletal muscle mass, is linked to cachexia, genetic disorders, and sarcopenia.
• The precise molecular mechanisms driving muscle atrophy remain incompletely understood.
• Identifying key regulatory genes is crucial for understanding and potentially treating muscle wasting.

Purpose of the Study:

• To investigate the role of Fbxw7β, an isoform of the Fbxw7 gene, in the development of muscle atrophy.
• To elucidate the molecular pathways through which Fbxw7β influences muscle cell differentiation and atrophy.
• To determine if Fbxw7β could serve as a therapeutic target for skeletal muscle atrophy.

Main Methods:

• Overexpression of Fbxw7β in vitro and in vivo to assess its effects on myogenin and atrogene markers (atrogin-1, MuRF-1).
• Treatment of primary myoblasts with dexamethasone to mimic muscle atrophy and observe endogenous Fbxw7β expression.
• Functional analysis using short hairpin RNA (shRNA) and a dominant-negative Fbxw7β mutant (ΔFbox) in vitro and in vivo.
• Evaluation of muscle fiber size and atrogene expression in vivo following manipulation of Fbxw7β.

Main Results:

• Ectopic Fbxw7β overexpression induced myogenin and atrogene expression while inhibiting myoblast differentiation.
• Dexamethasone treatment upregulated endogenous Fbxw7β, myogenin, and atrogene expression in primary myoblasts.
• Functional inhibition of Fbxw7β (using shRNA or ΔFbox) prevented muscle atrophy phenotypes in vitro and in vivo.
• The ΔFbox mutant did not affect muscle fiber size or induce atrogene expression in vivo, confirming Fbxw7β's specific role.

Conclusions:

• Fbxw7β is demonstrated as a key inducer of muscle atrophy phenotypes in adult muscle precursor cells and myofibers.
• Fbxw7β exerts its effects by upregulating the expression of key atrogenes, including myogenin, atrogin-1, and MuRF-1.
• The Fbxw7β-mediated pathway represents a novel and potential therapeutic target for combating skeletal muscle atrophy and sarcopenia.